Kiernan T. DeAngelis's Insider Trades & SAST Disclosures

Kiernan T. DeAngelis's most recent trade in Humacyte Inc was a trade of 99,576 Stock Options (right to buy) done . Disclosure was reported to the exchange on Aug. 26, 2021.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Humacyte Inc
Kiernan T. DeAngelis Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Aug 2021 99,576 99,576 - - Stock Options (right to buy)
Humacyte Inc
Kiernan T. DeAngelis Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Aug 2021 1,575 1,575 - - Stock Options (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades